By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ironshore Pharmaceuticals 

10 Market Street, Suite 715
Camana Bay
George Town  Grand Cayman  KY1-9006  Cayman Islands
Phone: n/a Fax: n/a


Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Highland Therapeutics Inc., is a specialty pharmaceutical company that is leveraging its proprietary technology, DELEXIS®, to optimize the delivery of previously approved drug products.


CMO: Floyd R. Sallee

Key Statistics

Ownership: Subsidiary

Web Site: Ironshore Pharma


Company News
Ironshore Pharma Announces Appointment Of Seasoned Experts To Its Expanding Executive Team 6/6/2017 9:25:04 AM
Ironshore Pharma Presents Pivotal Trial Data At American Psychiatric Association Meeting 5/24/2017 6:51:15 AM
Ironshore Pharma Announces Positive HLD100 Results From Open-Label Tolerability Study In Pediatric ADHD Patients 4/12/2017 11:39:16 AM
Ironshore Pharma Release: Company Announces Closing Of $200 Million Financing 1/24/2017 10:46:57 AM
Ironshore Pharma Announces FDA Acceptance Of HLD200 New Drug Application For Treatment Of ADHD 12/15/2016 10:50:00 AM
Ironshore Pharma Presents New Pivotal Trial Data At AACAP Meeting 10/28/2016 9:26:19 AM
Ironshore Pharmaceuticals And CHADD To Raise Awareness About The Negative Impact Of ADHD During The Early Morning Routine 10/5/2016 8:17:00 AM